Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14614192 | 0.92 | FDPS (0.33) | FDPSTSHRTDP1 | |
| SCHEMBL13476669 | 0.82 | TSHR (0.38) | TSHRTDP1 | |
| SCHEMBL10714274 | 0.79 | FDPS (0.36) | FDPS | |
| SCHEMBL2488430 | 0.79 | FDPS (0.36) | FDPS | |
| Hydrochloric Acid SCHEMBL9350218 | 0.78 | FDPS (0.32) | FDPSTSHRTDP1 | |
| SCHEMBL867689 | 0.77 | FDPS (0.35) | FDPSTSHRTDP1 | |
| Water SCHEMBL7941483 | 0.77 | FDPS (0.35) | FDPS | |
| SCHEMBL22174217 | 0.76 | FDPS (0.31) | FDPS | |
| SCHEMBL308779 | 0.75 | FDPS (0.41) | FDPS | |
| SCHEMBL17800823 | 0.74 | FDPS (0.37) | FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4130191-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | NIPPON STEEL Chemical & Material Co., Ltd. (JP) | 2023-02-08 | — | — | EP | disclosed |
| US-20200270264-A1 | MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. | 2020-08-27 | — | — | US | disclosed |
| US-10662200-B2 | Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto | ARENA PHARMACEUTICALS, INC. (US) | 2020-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10662200-B2 | Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto | ADRB3, ADRB1, ADRB2 | FDPS 2546/4885TSHR 188/4885TDP1 4309/4885 |
| US-20200270264-A1 | MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATED THERETO | ADRB3, ADRB1, ADRB2 | FDPS 2546/4885TSHR 188/4885TDP1 4309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.